Diva Laboratories, Ltd.(TW:4153)
NT$31.30+0.35 (+3.47%)
TW:4153
Diva Laboratories, Ltd. financials statements
NT$31.30
At close:+0.35 (+3.47%)
Diva Laboratories, Ltd. (4153) Income Statement
Diva Laboratories, Ltd. Income Statement
Last quarter (Q2 2026), Diva Laboratories, Ltd.'s total revenue was NT$245.06M, a decrease of 1.24% from the same quarter last year. In Q2, Diva Laboratories, Ltd.'s net income was NT$31.36M. See Diva Laboratories, Ltd.’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| NT$ 868.84M | NT$ 862.32M | NT$ 893.84M | NT$ 949.20M | NT$ 712.23M | |
| NT$ 264.68M | NT$ 260.18M | NT$ 250.77M | NT$ 266.13M | NT$ 181.60M | |
| NT$ 154.78M | NT$ 157.61M | NT$ 158.62M | NT$ 180.32M | NT$ 157.69M | |
| Depreciation and Amortization | NT$ 10.16M | NT$ 10.94M | NT$ 9.06M | NT$ 10.10M | NT$ 13.71M |
| NT$ 112.42M | NT$ 127.10M | NT$ 101.22M | NT$ 132.28M | NT$ 42.29M | |
| NT$ 102.25M | NT$ 111.17M | NT$ 92.15M | NT$ 122.18M | NT$ 24.69M | |
| NT$ 6.50M | NT$ 4.78M | NT$ -4.38M | NT$ -17.19M | NT$ 3.70M | |
| NT$ 108.75M | NT$ 115.95M | NT$ 87.77M | NT$ 67.64M | NT$ 28.47M | |
| NT$ 90.54M | NT$ 93.66M | NT$ 73.62M | NT$ 49.66M | NT$ 21.86M | |
| Per Share Metrics | |||||
| Basic EPS | NT$ 1.54 | NT$ 1.60 | NT$ 1.25 | NT$ 0.85 | NT$ 0.37 |
| Diluted EPS | NT$ 1.54 | NT$ 1.59 | NT$ 1.25 | NT$ 0.84 | NT$ 0.37 |
| Weighted Average Shares Outstanding | 58.79M | 58.67M | 58.89M | 58.67M | 58.67M |
| Weighted Average Shares Outstanding (Diluted) | 58.79M | 58.92M | 58.90M | 58.83M | 58.79M |
Currency in TWD
